Sign Up to like & get
recommendations!
0
Published in 2017 at "RSC Advances"
DOI: 10.1039/c6ra28234b
Abstract: The clinical administration of epirubicin (Epi) in the treatment of cancer has been restricted, owing to its cardiotoxicity. Targeted delivery of anticancer agents could increase their therapeutic efficacy and decrease their off-target effects. In this…
read more here.
Keywords:
cancer;
epi ddn;
ddn;
ddn conjugate ... See more keywords